Cargando…
Association between plasma somatic copy number variations and response to immunotherapy in patients with programmed death-ligand 1-negative non-small cell lung cancer
OBJECTIVE: To determine how patients with non-small cell lung cancer (NSCLC) with programmed death-ligand 1 (PD-L1)-negative and/or a low tumor mutation burden status benefit from immune checkpoint inhibitors (ICI). METHODS: We determined the plasma cell-free DNA profiles of 25 patients with PD-L1-n...
Autores principales: | Zhang, Xiaochen, Wang, Yina, Xiang, Jingjing, Zhao, Pan, Xun, Yanping, Zhang, Shirong, Xu, Nong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047987/ https://www.ncbi.nlm.nih.gov/pubmed/35466753 http://dx.doi.org/10.1177/03000605221093222 |
Ejemplares similares
-
SCNVSim: somatic copy number variation and structure variation simulator
por: Qin, Maochun, et al.
Publicado: (2015) -
Controlled Somatic and Germline Copy Number Variation in the Mouse Model
por: Hérault, Yann, et al.
Publicado: (2010) -
Identification of somatic copy number variations in plasma cell free DNA correlating with intrinsic resistances to EGFR targeted therapy in T790M negative non-small cell lung cancer
por: Zhu, Lucheng, et al.
Publicado: (2020) -
The Human Genome Puzzle – the Role of Copy Number Variation in Somatic Mosaicism
por: Mkrtchyan, Hasmik, et al.
Publicado: (2010) -
Short somatic alterations at the site of copy number variation in breast cancer
por: Murakami, Fumi, et al.
Publicado: (2020)